Detalles de la búsqueda
1.
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med
; 384(20): 1885-1898, 2021 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33725432
2.
Growth Trajectories Over the First Year of Life Among Early-Treated Infants with Human Immunodeficiency Virus and Infants Who are Human Immunodeficiency Virus-Exposed Uninfected.
J Pediatr
; 270: 114018, 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38508485
3.
Disclosure to South African children about their own HIV status over time.
AIDS Care
; 35(3): 334-340, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34930060
4.
Predictors of Cell-Associated Human Immunodeficiency Virus (HIV)-1 DNA Over 1 Year in Very Early Treated Infants.
Clin Infect Dis
; 74(6): 1047-1054, 2022 03 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34185838
5.
Switch to Efavirenz Attenuates Lipoatrophy in Girls With Perinatal HIV.
J Pediatr Gastroenterol Nutr
; 72(1): e15-e20, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32804904
6.
Educational delays among children living with perinatally-acquired HIV in Johannesburg, South Africa.
AIDS Care
; 32(4): 438-444, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31288549
7.
Bone Quality Measured Using Calcaneal Quantitative Ultrasonography Is Reduced Among Children with HIV in Johannesburg, South Africa.
J Pediatr
; 215: 267-271.e2, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31474425
8.
Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial.
Clin Infect Dis
; 65(3): 477-485, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28419200
9.
Extent of disclosure: what perinatally HIV-infected children have been told about their own HIV status.
AIDS Care
; 29(3): 378-386, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27569657
10.
Dietary Inadequacies in HIV-infected and Uninfected School-aged Children in Johannesburg, South Africa.
J Pediatr Gastroenterol Nutr
; 65(3): 332-337, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28333766
11.
Decreased Vigorous Physical Activity in School-Aged Children with Human Immunodeficiency Virus in Johannesburg, South Africa.
J Pediatr
; 172: 103-9, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26922104
12.
Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation.
BMC Infect Dis
; 16: 56, 2016 Feb 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26831894
13.
Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial.
JAMA
; 314(17): 1808-17, 2015 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26529159
14.
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
PLOS Glob Public Health
; 4(4): e0002703, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38603677
15.
Reply to Van de Wijer et al.
Clin Infect Dis
; 66(7): 1151-1152, 2018 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29088332
16.
Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus.
J Pediatr
; 162(6): 1138-45, 1145.e1-2, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23312691
17.
Microbiota in the oral cavity of school-age children with HIV who started antiretroviral therapy at young ages in South Africa.
AIDS
; 37(10): 1583-1591, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37199568
18.
Safety surveillance for PrEP in pregnant and breastfeeding women.
Front Reprod Health
; 5: 1221101, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37854936
19.
T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa.
AIDS
; 37(1): 105-112, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36476455
20.
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial.
Lancet Infect Dis
; 23(3): 295-306, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36273491